BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 36259929)

  • 1. A Dynamic rRNA Ribomethylome Drives Stemness in Acute Myeloid Leukemia.
    Zhou F; Aroua N; Liu Y; Rohde C; Cheng J; Wirth AK; Fijalkowska D; Göllner S; Lotze M; Yun H; Yu X; Pabst C; Sauer T; Oellerich T; Serve H; Röllig C; Bornhäuser M; Thiede C; Baldus C; Frye M; Raffel S; Krijgsveld J; Jeremias I; Beckmann R; Trumpp A; Müller-Tidow C
    Cancer Discov; 2023 Feb; 13(2):332-347. PubMed ID: 36259929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for rRNA 2'-O-methylation plasticity: Control of intrinsic translational capabilities of human ribosomes.
    Erales J; Marchand V; Panthu B; Gillot S; Belin S; Ghayad SE; Garcia M; Laforêts F; Marcel V; Baudin-Baillieu A; Bertin P; Couté Y; Adrait A; Meyer M; Therizols G; Yusupov M; Namy O; Ohlmann T; Motorin Y; Catez F; Diaz JJ
    Proc Natl Acad Sci U S A; 2017 Dec; 114(49):12934-12939. PubMed ID: 29158377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of the rRNA methylation complex components in pediatric B-cell precursor acute lymphoblastic leukemia: A pilot study.
    Ussowicz M; Marcel V; Long FNV; Kazanowska B; Diaz JJ; Wołowiec D
    Adv Clin Exp Med; 2020 Jan; 29(1):107-113. PubMed ID: 32011831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long noncoding RNA HOTAIR promotes the self-renewal of leukemia stem cells through epigenetic silencing of p15.
    Gao S; Zhou B; Li H; Huang X; Wu Y; Xing C; Yu X; Ji Y
    Exp Hematol; 2018 Nov; 67():32-40.e3. PubMed ID: 30172749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ribosomal RNA 2'-O-methylation dynamics impact cell fate decisions.
    Häfner SJ; Jansson MD; Altinel K; Andersen KL; Abay-Nørgaard Z; Ménard P; Fontenas M; Sørensen DM; Gay DM; Arendrup FS; Tehler D; Krogh N; Nielsen H; Kraushar ML; Kirkeby A; Lund AH
    Dev Cell; 2023 Sep; 58(17):1593-1609.e9. PubMed ID: 37473757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The rarity of ALDH(+) cells is the key to separation of normal versus leukemia stem cells by ALDH activity in AML patients.
    Hoang VT; Buss EC; Wang W; Hoffmann I; Raffel S; Zepeda-Moreno A; Baran N; Wuchter P; Eckstein V; Trumpp A; Jauch A; Ho AD; Lutz C
    Int J Cancer; 2015 Aug; 137(3):525-36. PubMed ID: 25545165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single-Cell Gene Expression Analyses Reveal Distinct Self-Renewing and Proliferating Subsets in the Leukemia Stem Cell Compartment in Acute Myeloid Leukemia.
    Sachs K; Sarver AL; Noble-Orcutt KE; LaRue RS; Antony ML; Chang D; Lee Y; Navis CM; Hillesheim AL; Nykaza IR; Ha NA; Hansen CJ; Karadag FK; Bergerson RJ; Verneris MR; Meredith MM; Schomaker ML; Linden MA; Myers CL; Largaespada DA; Sachs Z
    Cancer Res; 2020 Feb; 80(3):458-470. PubMed ID: 31784425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Leukemia Stem Cells Phenotype Expression on Response to Induction Therapy in Acute Myeloid Leukemia Patients.
    Almohsen F; Al-Mudallal SS
    Cardiovasc Hematol Disord Drug Targets; 2020; 20(2):145-151. PubMed ID: 31438833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diminished AHR Signaling Drives Human Acute Myeloid Leukemia Stem Cell Maintenance.
    Ly M; Rentas S; Vujovic A; Wong N; Moreira S; Xu J; Holzapfel N; Bhatia S; Tran D; Minden MD; Draper JS; Hope KJ
    Cancer Res; 2019 Nov; 79(22):5799-5811. PubMed ID: 31519687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AML1-ETO requires enhanced C/D box snoRNA/RNP formation to induce self-renewal and leukaemia.
    Zhou F; Liu Y; Rohde C; Pauli C; Gerloff D; Köhn M; Misiak D; Bäumer N; Cui C; Göllner S; Oellerich T; Serve H; Garcia-Cuellar MP; Slany R; Maciejewski JP; Przychodzen B; Seliger B; Klein HU; Bartenhagen C; Berdel WE; Dugas M; Taketo MM; Farouq D; Schwartz S; Regev A; Hébert J; Sauvageau G; Pabst C; Hüttelmaier S; Müller-Tidow C
    Nat Cell Biol; 2017 Jul; 19(7):844-855. PubMed ID: 28650479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting leukemia stem cells in vivo with antagomiR-126 nanoparticles in acute myeloid leukemia.
    Dorrance AM; Neviani P; Ferenchak GJ; Huang X; Nicolet D; Maharry KS; Ozer HG; Hoellarbauer P; Khalife J; Hill EB; Yadav M; Bolon BN; Lee RJ; Lee LJ; Croce CM; Garzon R; Caligiuri MA; Bloomfield CD; Marcucci G
    Leukemia; 2015 Nov; 29(11):2143-53. PubMed ID: 26055302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bortezomib suppresses self-renewal and leukemogenesis of leukemia stem cell by NF-ĸB-dependent inhibition of CDK6 in MLL-rearranged myeloid leukemia.
    Zhou B; Qin Y; Zhou J; Ruan J; Xiong F; Dong J; Huang X; Yu Z; Gao S
    J Cell Mol Med; 2021 Mar; 25(6):3124-3135. PubMed ID: 33599085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tuning the ribosome: The influence of rRNA modification on eukaryotic ribosome biogenesis and function.
    Sloan KE; Warda AS; Sharma S; Entian KD; Lafontaine DLJ; Bohnsack MT
    RNA Biol; 2017 Sep; 14(9):1138-1152. PubMed ID: 27911188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of OncoSnoRNAs and Ribosomal RNA 2'-O-methylation in Cancer.
    Barros-Silva D; Klavert J; Jenster G; Jerónimo C; Lafontaine DLJ; Martens-Uzunova ES
    RNA Biol; 2021 Oct; 18(sup1):61-74. PubMed ID: 34775914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ribosomal RNA 2'-
    Khoshnevis S; Dreggors-Walker RE; Marchand V; Motorin Y; Ghalei H
    Proc Natl Acad Sci U S A; 2022 Mar; 119(12):e2117334119. PubMed ID: 35294285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of a leukemic stem cell gene expression signature with clinical outcomes in acute myeloid leukemia.
    Gentles AJ; Plevritis SK; Majeti R; Alizadeh AA
    JAMA; 2010 Dec; 304(24):2706-15. PubMed ID: 21177505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 2'-O-Methylation of Ribosomal RNA: Towards an Epitranscriptomic Control of Translation?
    Monaco PL; Marcel V; Diaz JJ; Catez F
    Biomolecules; 2018 Oct; 8(4):. PubMed ID: 30282949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute Myeloid Leukemia Stem Cell Heterogeneity and Its Clinical Relevance.
    Karantanos T; Jones RJ
    Adv Exp Med Biol; 2019; 1139():153-169. PubMed ID: 31134500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. WT1 facilitates the self-renewal of leukemia-initiating cells through the upregulation of BCL2L2: WT1-BCL2L2 axis as a new acute myeloid leukemia therapy target.
    Zhou B; Jin X; Jin W; Huang X; Wu Y; Li H; Zhu W; Qin X; Ye H; Gao S
    J Transl Med; 2020 Jun; 18(1):254. PubMed ID: 32580769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of biomarkers for acute leukemia via machine learning-based stemness index.
    Zhang Y; Liu D; Li F; Zhao Z; Liu X; Gao D; Zhang Y; Li H
    Gene; 2021 Dec; 804():145903. PubMed ID: 34411647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.